SCHEMBL23905759

SCHEMBL23905759

C=Cc1nc2c(OC3CC3)cc(C(=O)OC)cc2s1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.38
RAB9A P51151 4/20 0.38
HSP90AA1 P07900 1/20 0.38
ALDH1A1 P00352 3/20 0.36
EPHX2 P34913 1/20 0.34
KDM4E B2RXH2 2/20 0.34
PIK3CA P42336 1/20 0.33
PIK3CB P42338 1/20 0.33
PIK3CG P48736 1/20 0.33
PI4KB Q9UBF8 1/20 0.33
SMN1; SMN2 Q16637 4/20 0.33
MAPT P10636 3/20 0.33
MEN1 O00255 2/20 0.33
TNF P01375 2/20 0.33
LMNA P02545 2/20 0.33
GAA P10253 2/20 0.33
HPGD P15428 2/20 0.33
HTT P42858 2/20 0.33
KMT2A Q03164 2/20 0.33
MCL1 Q07820 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23905552 0.90 NPC1 (0.38) NPC1RAB9AHSP90AA1ALDH1A1EPHX2
SCHEMBL21262149 0.86 ALDH1A1 (0.42) NPC1RAB9AALDH1A1KDM4EPIK3CA
SCHEMBL20833630 0.83 NPC1 (0.43) NPC1RAB9AHSP90AA1ALDH1A1EPHX2
SCHEMBL20833809 0.82 CYP2C9 (0.42) NPC1RAB9AHSP90AA1ALDH1A1EPHX2
SCHEMBL23905542 0.81 ACACB (0.39) NPC1RAB9AHSP90AA1ALDH1A1EPHX2
SCHEMBL23905898 0.81 RAB9A (0.38) NPC1RAB9AHSP90AA1ALDH1A1EPHX2
SCHEMBL23905762 0.79 HSD17B10 (0.32) HSD17B10
SCHEMBL21262000 0.78 LMNA (0.48) NPC1RAB9AHSP90AA1ALDH1A1KDM4E
SCHEMBL20094483 0.74 ALDH1A1 (0.43) NPC1RAB9AALDH1A1KDM4EPIK3CA
SCHEMBL20817424 0.73 PDE4D (0.43) NPC1RAB9AHSP90AA1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021198981-A1 ANTIVIRAL COMPOUNDS AND USES THEREOF Janssen Biopharma, Inc. (US) 2021-10-07 WO disclosed